Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPA1 | O75762 | 3/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.36 |
| ▸ | HPGD | P15428 | 2/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | TERT | O14746 | 1/20 | 0.31 |
| ▸ | MDM4 | O15151 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | CTSL | P07711 | 1/20 | 0.31 |
| ▸ | CTSB | P07858 | 1/20 | 0.31 |
| ▸ | SLC25A21 | Q9BQT8 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6344313 | 0.75 | TRPA1 (0.39) | TRPA1ALDH1A1CYP3A4HPGDALOX15 | |
| SCHEMBL1927751 | 0.70 | — | — | |
| SCHEMBL2460763 | 0.70 | — | — | |
| SCHEMBL4565340 | 0.70 | — | — | |
| Diallylsulfone SCHEMBL9246095 | 0.68 | ALOX5 (0.58) | TRPA1ALDH1A1CYP3A4HPGDALOX15 | |
| SCHEMBL9617822 | 0.65 | ALOX5 (0.46) | TRPA1ALDH1A1CYP3A4HPGDALOX15 | |
| SCHEMBL7877039 | 0.65 | — | — | |
| Diallyl Sulfide SCHEMBL22320280 | 0.65 | ALOX5 (0.52) | TRPA1ALDH1A1CYP3A4HPGDALOX15 | |
| SCHEMBL7877037 | 0.65 | — | — | |
| Diallylsulfone SCHEMBL9947 | 0.64 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 64 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230343929-A1 | COMPOSITE POSITIVE ELECTRODE MATERIAL, PREPARATION METHOD THEREFOR, AND APPLICATION IN ZINC ION BATTERY | LANGFANG TECHNOLOGICAL SERVICE CENTER OF GREEN INDUSTRY (CN) | 2023-10-26 | — | — | US | claimed |
| CN-109698356-B | Positive electrode material modifier and preparation method and application thereof | 中科廊坊过程工程研究院 | 2022-04-29 | — | — | CN | claimed |
| CN-109638257-B | Composite vanadium pentoxide material and preparation method and application thereof | 中科廊坊过程工程研究院 | 2022-04-26 | — | — | CN | claimed |
| CN-111554931-B | Composite positive electrode material, preparation method thereof and application thereof in zinc ion battery | 中科廊坊过程工程研究院 | 2021-09-14 | — | — | CN | claimed |
| CN-108511751-B | Modified lithium iron phosphate, preparation method thereof and lithium ion battery | 中科锂电新能源有限公司 | 2021-02-02 | — | — | CN | claimed |
| CN-107706403-B | Composite carbon material, modified electrode material prepared from same and lithium ion battery | 中国科学院过程工程研究所 | 2020-09-25 | — | — | CN | claimed |
| CN-111554931-A | Composite positive electrode material, preparation method thereof and application thereof in zinc ion battery | 中科廊坊过程工程研究院 | 2020-08-18 | — | — | CN | claimed |
| WO-2013124441-A1 | USE OF DIALKYL-THIOSULFINATE AND/OR THIOSULFONATE TO IMPROVE THE RESISTANCE OF AN ANIMAL INFECTED BY A PATHOGEN | PANCOSMA S.A. (CH) | 2013-08-29 | — | — | WO | claimed |
| US-20240216350-A1 | SEMI-SOLID TOPICAL COMPOSITION CONTAINING PIRFENIDONE AND MODIFIED DIALLYL DISULFIDE OXIDE (M-DDO) FOR ELIMINATING OR PREVENTING ACNE | EXCALIBUR PHARMACEUTICALS, INC. (US) | 2024-07-04 | — | — | US | disclosed |
| US-20230343929-A1 | COMPOSITE POSITIVE ELECTRODE MATERIAL, PREPARATION METHOD THEREFOR, AND APPLICATION IN ZINC ION BATTERY | LANGFANG TECHNOLOGICAL SERVICE CENTER OF GREEN INDUSTRY (CN) | 2023-10-26 | — | — | US | disclosed |
| US-11766426-B2 | Semi-solid topical composition containing pirfenidone and modified diallyl disulfide oxide (M-DDO) for eliminating or preventing acne | EXCALIBUR PHARMACEUTICALS, INC. (US) | 2023-09-26 | — | — | US | disclosed |
| CN-109698356-B | Positive electrode material modifier and preparation method and application thereof | 中科廊坊过程工程研究院 | 2022-04-29 | — | — | CN | disclosed |
| CN-109638257-B | Composite vanadium pentoxide material and preparation method and application thereof | 中科廊坊过程工程研究院 | 2022-04-26 | — | — | CN | disclosed |
| CN-109817940-B | Modified material and preparation method thereof, and iron phosphate vanadium manganese lithium anode material containing modified material and preparation method thereof | 廊坊绿色工业技术服务中心 | 2022-03-01 | — | — | CN | disclosed |
| CN-1948394-A | Polymer/montmorillonite-gallicin nano-antibacterial composite material and its preparation method | NANJING UNIVERSITY OF TECHNOLOGY (CN) | 2007-04-18 | — | — | CN | disclosed |
| CN-1818045-A | Method for extracting allium sativum oil and allium sativum polyose from garlic by supercritical CO2 | JIANZHIYUAN FOOD CO LTD KAIPIN (CN) | 2006-08-16 | — | — | CN | disclosed |
| CN-1683332-A | Method for extracting garlicin | UNIV CHINA AGRICULTURAL (CN) | 2005-10-19 | — | — | CN | disclosed |
| US-20030077264-A1 | Antimicrobial blood treatment using allicin and related compounds | GAMBRO, INC. | 2003-04-24 | — | — | US | disclosed |
| WO-2003018080-A1 | LOCAL DRUG DELIVERY SYSTEM IN CORONARY STENTS | SAHAJANAND BIOTECH PRIVATE LIMITED (IN) | 2003-03-06 | — | — | WO | disclosed |
| WO-2003018082-A2 | LOCAL DRUG DELIVERY SYSTEM IN CORONARY STENTS | SAHAJANAND BIOTECH PRIVATE LIMITED (IN) | 2003-03-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240216350-A1 | SEMI-SOLID TOPICAL COMPOSITION CONTAINING PIRFENIDONE AND MODIFIED DIALLYL DISULFIDE OXIDE (M-DDO) FOR ELIMINATING OR PREVENTING ACNE | DAO, DDO, CUTA | TRPA1 596/4885ALDH1A1 260/4885CYP3A4 567/4885 |
| US-20030077264-A1 | Antimicrobial blood treatment using allicin and related compounds | JAK2, GART, F8 | TRPA1 1335/4885ALDH1A1 2642/4885CYP3A4 1893/4885 |
| US-11766426-B2 | Semi-solid topical composition containing pirfenidone and modified diallyl disulfide oxide (M-DDO) for eliminating or preventing acne | DAO, DDO, CUTA | TRPA1 596/4885ALDH1A1 260/4885CYP3A4 567/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.